MIKAVIN 500 is a powerful aminoglycoside antibiotic used for treating serious and
hospital-acquired infections caused by Gram-negative and some Gram-positive bacteria. It acts
by inhibiting bacterial protein synthesis, leading to effective bacterial eradication, even in
resistant cases.
Key Benefits
● Broad-spectrum action against severe infections
● Effective against multidrug-resistant bacteria
● Rapid bactericidal activity via IM/IV route
● Trusted in critical care and hospital settings
Indications
● Severe respiratory tract infections
● Complicated urinary tract infections
● Intra-abdominal and bloodstream infections
● Bone, joint, and soft tissue infections
● Post-surgical and hospital-acquired infections